GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,859,000 | +118.8% | 56,676 | +2.6% | 0.00% | +100.0% |
| Q2 2022 | $1,764,000 | -1.3% | 55,231 | +7.0% | 0.00% | 0.0% |
| Q1 2022 | $1,788,000 | +22.9% | 51,616 | +3.9% | 0.00% | – |
| Q4 2021 | $1,455,000 | +13.8% | 49,698 | -0.8% | 0.00% | – |
| Q3 2021 | $1,278,000 | -5.1% | 50,123 | +30.4% | 0.00% | – |
| Q2 2021 | $1,346,000 | -18.0% | 38,443 | -4.6% | 0.00% | -100.0% |
| Q1 2021 | $1,642,000 | +3.8% | 40,297 | +10.3% | 0.00% | 0.0% |
| Q4 2020 | $1,582,000 | -40.3% | 36,518 | -24.1% | 0.00% | 0.0% |
| Q3 2020 | $2,652,000 | -13.1% | 48,099 | -0.5% | 0.00% | 0.0% |
| Q2 2020 | $3,051,000 | +73.4% | 48,323 | +40.3% | 0.00% | 0.0% |
| Q1 2020 | $1,760,000 | -40.2% | 34,442 | -7.0% | 0.00% | 0.0% |
| Q4 2019 | $2,944,000 | +101.5% | 37,040 | +23.0% | 0.00% | 0.0% |
| Q3 2019 | $1,461,000 | +4.2% | 30,120 | +13.0% | 0.00% | 0.0% |
| Q2 2019 | $1,402,000 | +16.4% | 26,666 | +17.2% | 0.00% | 0.0% |
| Q1 2019 | $1,204,000 | +34.7% | 22,745 | +4.4% | 0.00% | 0.0% |
| Q4 2018 | $894,000 | +30.3% | 21,779 | +20.6% | 0.00% | – |
| Q3 2018 | $686,000 | -5.8% | 18,065 | +12.3% | 0.00% | -100.0% |
| Q2 2018 | $728,000 | -1.5% | 16,092 | +5.2% | 0.00% | 0.0% |
| Q1 2018 | $739,000 | +99.2% | 15,299 | +63.5% | 0.00% | – |
| Q4 2017 | $371,000 | +24.1% | 9,357 | -4.3% | 0.00% | – |
| Q3 2017 | $299,000 | +16.8% | 9,775 | +4.9% | 0.00% | – |
| Q2 2017 | $256,000 | +43.8% | 9,315 | +93.4% | 0.00% | – |
| Q1 2017 | $178,000 | +187.1% | 4,816 | +10.1% | 0.00% | – |
| Q4 2016 | $62,000 | +31.9% | 4,376 | +106.0% | 0.00% | – |
| Q3 2016 | $47,000 | -36.5% | 2,124 | -52.9% | 0.00% | – |
| Q2 2016 | $74,000 | – | 4,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |